Zhongwu Li Selected Research

NU 1025

7/2021

HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhongwu Li Research Topics

Disease

65	Neoplasms (Cancer) 04/2022 - 07/2009
29	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2007
14	Carcinogenesis 01/2021 - 11/2007
11	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2017
10	Neoplasm Metastasis (Metastasis) 06/2022 - 03/2015
10	Melanoma (Melanoma, Malignant) 08/2021 - 12/2010
7	Breast Neoplasms (Breast Cancer) 04/2022 - 07/2009
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2022 - 12/2014
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
5	Adenocarcinoma 07/2022 - 06/2018
5	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2015
3	Microsatellite Instability 01/2022 - 11/2020
3	Lung Neoplasms (Lung Cancer) 11/2019 - 12/2011
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2018 - 01/2015
3	Tongue Neoplasms (Tongue Neoplasm) 02/2015 - 12/2013
2	Epstein-Barr Virus Infections 05/2021 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 08/2011
2	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 01/2019 - 01/2016
2	Rectal Neoplasms (Rectal Cancer) 11/2018 - 10/2014
2	Pathologic Processes 05/2018 - 11/2007
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2017 - 01/2013
2	Mouth Neoplasms (Oral Cancer) 04/2016 - 01/2015
1	Residual Neoplasm 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Solitary Fibrous Tumors 11/2021
1	Heavy Metal Poisoning 05/2021
1	Turcot syndrome 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Lymphatic Metastasis 11/2020

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
20	Proteins (Proteins, Gene)FDA Link 07/2022 - 07/2009
14	Messenger RNA (mRNA)IBA 01/2022 - 10/2013
12	Biological ProductsIBA 11/2021 - 11/2007
8	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2017
7	Pharmaceutical PreparationsIBA 01/2021 - 05/2016
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2011
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 12/2010
4	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2016
4	Monoclonal AntibodiesIBA 01/2018 - 01/2013
3	B7-H1 AntigenIBA 04/2022 - 05/2018
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2021 - 08/2019
3	SynaptophysinIBA 08/2021 - 01/2018
3	Chromogranin AIBA 08/2021 - 01/2016
3	LigandsIBA 05/2021 - 11/2015
3	ChromatinIBA 01/2021 - 12/2014
3	AfatinibIBA 11/2019 - 01/2018
3	Histones (Histone)IBA 01/2019 - 12/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2007
3	Trastuzumab (Herceptin)FDA Link 01/2018 - 11/2015
2	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2018
2	NucleotidesIBA 06/2021 - 01/2016
2	Circulating Tumor DNAIBA 01/2021 - 09/2017
2	CateninsIBA 01/2021 - 04/2017
2	Tumor Biomarkers (Tumor Markers)IBA 11/2020 - 01/2015
2	ParaffinIBA 10/2020 - 11/2015
2	Formaldehyde (Formol)FDA Link 10/2020 - 11/2015
2	PlatinumIBA 11/2019 - 08/2016
2	Antisense OligonucleotidesIBA 10/2019 - 01/2019
2	Long Noncoding RNAIBA 10/2019 - 01/2019
2	Antisense RNA (Anti-Sense RNA)IBA 10/2019 - 01/2019
2	Therapeutic UsesIBA 01/2019 - 01/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2018 - 08/2016
2	adavosertibIBA 06/2018 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 06/2018 - 07/2017
2	Lysine (L-Lysine)FDA Link 05/2018 - 12/2013
2	dactolisibIBA 01/2018 - 11/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 04/2017
2	Cetuximab (Erbitux)FDA Link 01/2018 - 10/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 09/2014
2	Polycomb Repressive Complex 2IBA 01/2018 - 01/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2017 - 04/2017
2	Imatinib Mesylate (Gleevec)FDA Link 09/2017 - 05/2016
2	5-hydroxymethylcytosineIBA 08/2017 - 01/2016
2	Histone DemethylasesIBA 04/2016 - 02/2015
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	human ERBB2 proteinIBA 07/2022
1	contrast agent BR1IBA 06/2022
1	SonazoidIBA 06/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 11/2021
1	eburnamonine (vinburnine)IBA 07/2021
1	Thiamine (Aneurin)FDA Link 07/2021
1	NU 1025IBA 07/2021
1	Phosphates (Orthophosphate)IBA 05/2021
1	Heavy MetalsIBA 05/2021
1	pembrolizumabIBA 01/2021
1	regorafenibIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 12/2020

Therapy/Procedure

19	Therapeutics 03/2022 - 01/2013
11	Drug Therapy (Chemotherapy) 06/2022 - 07/2009
7	Neoadjuvant Therapy 03/2022 - 08/2016
2	Immunotherapy 01/2022 - 12/2020
2	Precision Medicine 01/2021 - 01/2017
2	Adjuvant Chemotherapy 11/2019 - 10/2018
1	Gastrectomy 01/2021